Sinterx Pharma Private Limited - Company overview

Registered with ROC Hyderabad on 26 August 2021, Sinterx Pharma Private Limited is an active private limited company that has been around fo…

2021-08-26 Seri Lingampally, Telangana Active Unlisted
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹25–50 Cr
▲ 172.7%
FY 2023
PROFIT / LOSS
₹1–5 Cr
▲ 226.9%
FY 2023
EBITDA
₹1–5 Cr
▲ 222.6%
FY 2023
NET WORTH
₹1–5 Cr
▲ 266.4%
FY 2023
TOTAL ASSETS
₹10–25 Cr
▲ 48.0%
FY 2023
EMPLOYEE COUNT
11–20
OPEN CHARGES
2
-
PAID-UP CAPITAL
7.50 Lakh
AUTHORISED CAPITAL
10.00 Lakh
COMPANY AGE
5 Years 2 Months
since 2021-08-26
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-30
ACTIVE GST
1
Updated: 2024-12-13 03:24:35
TOTAL MONEY RAISED
₹10–50 Lakh
SATISFIED CHARGES
1
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Sinterx Pharma Private Limited covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Low risk
89/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (88), financial health (90), director (95) and company-foundation signals.
  • Operating for 5 years.
Compliance Score Low risk
88/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score Low risk
90/100
Profitability, leverage and liquidity from filed statements.
  • Profitable in FY 2023.
  • Positive net worth.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 3 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Sinterx Pharma Private Limited Company identity, industry, contact, and registration details from MCA and company records.

Registered with ROC Hyderabad on 26 August 2021, Sinterx Pharma Private Limited is an active private limited company that has been around for about 5 years. The registered office is at Flat No 201 Sai Acrade, Plot No.18, Seri Lingampally, Telangana.

In its MCA filings the main business is listed as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 100% of turnover.

It has three directors: Sruthi Medapati, Deepika Punnapu and Golla Padmavathi. The longest-serving is Sruthi Medapati, on the board since 2021; the most recent to join is Deepika Punnapu, appointed in August 2022. Two former directors are on record; the most recent to leave was Srinivas Reddy Karka in January 2023.

₹7.5 lakh of its ₹10 lakh authorised capital is paid up (about 75%). Its latest balance sheet on MCA is for the year ending 31 March 2025, and the last AGM was on 30 September 2025. Two charges (secured loans) are still open, and one more has been paid off.

Pharma ••••••••
  • Location Flat No 201 Sai Acrade, Plot No.18, Seri Lingampally, Telangana - 500032
Legal NameSinterx Pharma Private Limited
CIN / LLPINU24299TG2021PTC154397
Company No.154397
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2021-08-26
Date of AGM2025-09-30
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Hyderabad
PAN
LEI Number
Active Compliance-

Current Directors of Sinterx Pharma Private Limited (3) Current board members from MCA filings, including designation and appointment details.

S
Director | Since 2021-08-26 | DIN: 09295524
D
Director | Since 2022-08-26 | DIN: 09353647
G
Director | Since 2021-12-01 | DIN: 09355599

Financial Performance of Sinterx Pharma Private Limited Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹25–50 Cr ▲ 172.7%
P&L ₹1–5 Cr ▲ 226.9%
EBITDA ₹1–5 Cr ▲ 222.6%
Net worth ₹1–5 Cr ▲ 266.4%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Sinterx Pharma Private Limited Open and satisfied charges registered against the company with MCA.

Others : 27.00 cr
Axis Bank Limited : 4.05 cr
Open Charges: 2 Satisfied Charges: 1
Open -
Satisfied 0
LenderAmountStatus
Others
Creation Date: 14 Aug 2025
25.00 cr Open
Others
Creation Date: 14 Aug 2025
2.00 cr Open
Axis Bank Limited
Creation Date: 23 Aug 2024
4.05 cr Closed

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products100

Financial Ratios of Sinterx Pharma Private Limited Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

2 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Sinterx Pharma Private Limited Ownership and contribution detail from filings. Full breakdown unlocks with your report.

1 shareholder category on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

Employees and EPFO Compliance at Sinterx Pharma Private Limited EPFO establishments, contributions, and headcount history. Full records unlock with your report.

1 establishment linked

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

Monthly headcount PF contributions ECR filing status Establishment history

Employee and EPFO history require an active report plan.

Verified entity values are shown only after access is granted.

GST Compliance of Sinterx Pharma Private Limited GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sinterx Pharma Private Limited MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sinterx Pharma Private Limited Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sinterx Pharma Private Limited Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Sinterx Pharma Private Limited?
MCA does not publish an "owner" field. Sinterx Pharma Private Limited is run by its directors, Sruthi Medapati, Deepika Punnapu and Golla Padmavathi. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Sinterx Pharma Private Limited?
Sinterx Pharma Private Limited has three current directors: Sruthi Medapati (since August 2021), Deepika Punnapu (since August 2022) and Golla Padmavathi (since December 2021).
What is CIN of Sinterx Pharma Private Limited?
The CIN of Sinterx Pharma Private Limited is U24299TG2021PTC154397. Reading it left to right: U means it is not listed, 24299 is the industry code it registered under, TG is Telangana, 2021 is the year it was registered, PTC is the company type and 154397 is its registration number.
When was Sinterx Pharma Private Limited incorporated?
Sinterx Pharma Private Limited was incorporated on 26 August 2021 with ROC Hyderabad. That makes it about 5 years old.
What is the registered address of Sinterx Pharma Private Limited?
The registered office on MCA records is Flat No 201 Sai Acrade, Plot No.18, Seri Lingampally, Telangana - 500032.
What is the current status of Sinterx Pharma Private Limited?
MCA shows Sinterx Pharma Private Limited as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Sinterx Pharma Private Limited?
You can post to its registered office at Flat No 201 Sai Acrade, Plot No.18, Seri Lingampally, Telangana - 500032.
What industry or business activity is Sinterx Pharma Private Limited associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (100% of turnover).
What is paid-up capital and authorised share capital of Sinterx Pharma Private Limited?
Paid-up capital is ₹7.5 lakh and authorised capital is ₹10 lakh, so about 75% of the authorised amount has been issued.
When did Sinterx Pharma Private Limited last file accounts and hold an AGM?
The last AGM on record was on 30 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Sinterx Pharma Private Limited?
Two charges against Sinterx Pharma Private Limited are still open and one has been satisfied. Lenders named in the filings include Axis Bank Limited.
Have any directors left Sinterx Pharma Private Limited?
Yes, two former directors are on record. The most recent to leave were Srinivas Reddy Karka (January 2023) and Lavanya Angadi (July 2022).
What is the turnover or revenue of Sinterx Pharma Private Limited?
Based on filed financial statements, the revenue of Sinterx Pharma Private Limited for FY 2023 was in the ₹25–50 Cr range. That is up 172.7% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Sinterx Pharma Private Limited?
For FY 2023, the net worth of Sinterx Pharma Private Limited was in the ₹1–5 Cr range.
How can I get the financial details of Sinterx Pharma Private Limited?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
Sinterx Pharma Private Limited - is it listed or unlisted?
Sinterx Pharma Private Limited is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Sinterx Pharma Private Limited?
Sinterx Pharma Private Limited is registered with ROC Hyderabad.
What is the company classification of Sinterx Pharma Private Limited?
MCA classifies Sinterx Pharma Private Limited as: Private Limited Indian Non-Government Company.
Does Sinterx Pharma Private Limited have GST registrations on file?
Yes, one active GST registration is linked to Sinterx Pharma Private Limited.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.